The treatment of Candidiasis & Dermatitis Herpetiformis with vitamins

Candidiasis and Dermatitis Herpetiformis: Mitamins custom make quality formulas for the treatment of Candidiasis & Dermatitis Herpetiformis with vitamins. A Candidiasis & Dermatitis Herpetiformis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Candidiasis and Dermatitis Herpetiformis

  • Amount Per Serving
    % DV
    Vitamin C
    500
    mg
    833%
    Zinc
    20
    mg
    133%
    Selenium
    100
    mcg
    143%
    Lactobacillus acidolphilus
    100
    mg
    *
    Flax Seed Powder
    100
    mg
    *
  • Amount Per Serving
    % DV
    MSM
    250
    mg
    *
    Bioflavonoid Concentrate
    200
    mg
    *
    Garlic Extract
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Candidiasis and Dermatitis Herpetiformis
Serving Size:4-5

Candidiasis and Dermatitis Herpetiformis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
European Committee Issues Positive Opinion On Wyeth's TORISEL For Advanced Renal Cell Carcinoma
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced that it has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA) for the approval of TORISEL? (temsirolimus) as a first-line therapy for patients with advanced renal cell carcinoma (RCC) who have at least three of six prognostic risk factors.
Web Site Helps Men Evaluate Risk Of Prostate Cancer
In 2007, more than 218,000 American men will be diagnosed with prostate cancer, and more than 27,000 men will die from the disease.
This information concerning the support of Candidiasis and Dermatitis Herpetiformis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments